Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Nicotine inhaler launched in U.S.

March 2, 1998

The role of dopamine D2 receptor in alcohol intake suppression

Feb. 17, 1998

Orally active iron chelators in development at Novartis

Feb. 16, 1998

TheraTech and SmithKline Beecham join forces on nicotine product

Feb. 3, 1998

Dual 5-HT reuptake inhibitors/5-HT1A antagonists developed at Lilly

Jan. 26, 1998

New chelating agent developed by Israeli researchers

Jan. 21, 1998

U.K. launch for inhaled nicotine replacement therapy

Dec. 23, 1997

Antizol cleared by FDA as first antidote for ethylene glycol poisoning

Dec. 19, 1997

U. of Florida prepares new metal chelators

Dec. 18, 1997

AMPA antagonist investigated for treatment of drug withdrawal

Dec. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...